Research and Markets (http://www.researchandmarkets.com/research/2fgrr2/food) has announced the addition of the "Food Allergy-Pipeline Insights, 2014" subscription to their offering.
This Food Allergy-Pipeline Insights, 2014, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Food Allergy.
This report provides information on the therapeutic development based on the Food Allergy dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed, Preclinical, Discovery and unknown stages, therapeutics assessment by monotherapy and combination products and molecule type drug information.
The report also covers the companies information involved in the therapeutic development of the products. It also has highlighted the discontinued and dormant products.
Key Topics Covered:
- Food Allergy Overview
- Food Allergy Pipeline Therapeutics
- Food Allergy Therapeutics under Development by Companies
- Food Allergy Late Stage Products (Filed and Phase III)
- Comparative Analysis
- Food Allergy Mid Clinical Stage Products (Phase II)
- Comparative Analysis
- Food Allergy Early Clinical Stage Products (Phase I and IND Filed)
- Comparative Analysis
- Food Allergy Discovery and Pre-Clinical Stage Products
- Comparative Analysis
- Drug Candidate Profiles
- Food Allergy - Therapeutics Assessment
- Assessment by Monotherapy Products
- Assessment by Combination Products
- Assessment by Route of Administration
- Assessment by Molecule Type
- Food Allergy - Discontinued Products
- Food Allergy - Dormant Products
- Companies Involved in Therapeutics Development for Food Allergy
- Appendix
For more information visit http://www.researchandmarkets.com/research/2fgrr2/food